UBIO

ProShares UltraPro Nasdaq Biotechnology

UBIO Fund Description

The ProShares UltraPro NASDAQ Biotechnology provides 3x daily exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ.

UBIO Factset Analytics Insight

UBIO is the newest leveraged play on the NASDAQ Biotechnology Index, this one being 3x the exposure of the daily gains of the index, as opposed to the established and successful 2x iteration of sister fund BIB. The index is also tracked in unlevered form by the hugely popular iShares’ IBB. UBIO gains its 3x leveraged exposure to the index through a mix of equity and swap agreements, and rebalances its exposure daily. UBIO is the second triple-leveraged biotech fund, following hot on the heels of Direxion’s LABU, which was launched a month earlier. Like all geared funds that rebalance daily, UBIO is meant for short-term trading, since compounding effects over the long term could create vast differences from expected returns relative to the index—for good or for ill. Trade this fund with limit orders.

UBIO MSCI ESG Analytics Insight

The MSCI ESG Fund Quality Score measures the ability of ETF underlying holdings to manage key medium to long-term risks and opportunities arising from environmental, social, and governance factors, as determined by MSCI ESG Research LLC. As of November 21, 2017 the ProShares UltraPro Nasdaq Biotechnology MSCI ESG Fund Quality Score is 4.43 out of 10.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. UBIO ranks in the 0th percentile within its peer group and in the 17th percentile within the global universe of all funds in MSCI ESG Fund Metrics coverage.

  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
COMPARE
RESET
Select ETFs to compare their performance:
Bats Book Viewer
TOP OF BOOK
SHARES/SIZEPRICE
ASKS----
----
----
----
----
BIDS----
----
----
----
----
LAST 10 TRADES
TIMEPRICESHARES
12:53:0331.15100
10:39:1631.30100
10:39:1631.30100
09:43:0331.08100
09:40:5531.00145
------
------
------
------
------
Bats BZX Real-time Quote - 23:59:59
Daily Spread
Premium/Discount
Volume

UBIO Factset Analytics Block Liquidity

As of 11/22/17
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of UBIO. UBIO is rated a N/A out of 5.

UBIO Summary Data

ProShares
06/23/15
Open-Ended Fund
0.95%
$46.59M
0.29%

UBIO Portfolio Data

0.00%
12/26/17

UBIO Index Data

Market Cap
NASDAQ - Listed
N/A

UBIO Fund Structure

Yes
No
No Policy
N/A
N/A
Medium
3
Daily

UBIO Tax Exposures

20% / 39.6%
--
No

UBIO Tradability

90,968
$3.18M
82,158
$2.9M
0.29%
-0.02%
0.43% / -0.74%
None
50,000
1.64
0.02%
561
$30.92
N/A

UBIO MSCI ESG Ratings

4.43 / 10
--
17.04
--
32.43%
19.07